Insider Selling: Nukkleus (NASDAQ:NUKK) Insider Sells 30,000 Shares of Stock

Nukkleus Inc. (NASDAQ:NUKK) insider Anastasiia Kotaieva sold 30,000 shares of Nukkleus stock in a transaction dated Monday, December 22nd. The stock was sold at an average price of $4.41, for a total value of $132,300.00. Following the completion of the sale, the insider directly owned 1,331,197 shares in the company, valued at $5,870,578.77. This trade represents a 2.20% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Anastasiia Kotaieva also recently made the following trade(s):

• On Friday, December 26th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The shares were sold at an average price of $4.26, for a total transaction of $236,873.04.
• On Wednesday, December 24th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.49, for a total value of $249,661.96.
• On Tuesday, December 23rd, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.57, for a total value of $319,900.00.
• On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.53, for a total transaction of $317,100.00.
• On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The shares were sold at an average price of $4.72, for a total value of $182,871.68.

Nukkleus Stock Performance

Nukkleus stock traded up $0.14 during mid-day trading on Wednesday, hitting $4.17. The company’s stock had a trading volume of 355,807 shares, compared to its average volume of 1,721,200. The company has a 50 day moving average of $5.68 and a 200-day moving average of $6.79. Nukkleus Inc. has a one year low of $3.31 and a one year high of $40.98. The stock has a market cap of $69.43 million, a PE ratio of 0.25 and a beta of -6.75.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on NUKK. Wall Street Zen upgraded shares of Nukkleus from a “sell” rating to a “hold” rating in a report on Sunday, November 23rd. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Nukkleus in a research report on Wednesday, December 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Nukkleus currently has a consensus rating of “Sell”.

Institutional Trading of Nukkleus

Several hedge funds and other institutional investors have recently made changes to their positions in the business. BNP Paribas Financial Markets purchased a new position in shares of Nukkleus in the 2nd quarter valued at approximately $56,000. Ausdal Financial Partners Inc. purchased a new stake in Nukkleus during the 3rd quarter worth approximately $105,000. Finally, UBS Group AG increased its stake in Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after purchasing an additional 15,223 shares in the last quarter. Hedge funds and other institutional investors own 12.47% of the company’s stock.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.